Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $418.6200 (-0.92%) ($415.5800 - $422.6100) on Thu. Feb. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 40 | Latest Price | $418.6200(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -0.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.04% in a week (0% probabilities). VXX(-11%) UUP(-11%) TLT(-6%) IFRA(-5%) XHB(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $420.13(-0.36%) | 10 Day Moving Average | $415.43(0.77%) | 20 Day Moving Average | $417.04(0.38%) | To recent high | -2.7% | To recent low | 22.9% | Market Cap | $44.386b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |